Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.84)
# 427
Out of 5,060 analysts
344
Total ratings
50%
Success rate
26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Reiterated: Buy | $35 | $19.03 | +83.92% | 49 | Oct 2, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $42 | $13.47 | +211.80% | 7 | Sep 30, 2026 | |
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $33 | $9.55 | +245.55% | 43 | Sep 30, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $125 | $72.09 | +73.39% | 25 | Sep 29, 2026 | |
| IVA Inventiva | Reiterated: Buy | $14 | $2.94 | +376.19% | 13 | Sep 28, 2026 | |
| ABSI Absci | Reiterated: Buy | $16 | $8.25 | +93.94% | 2 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $8 | $2.13 | +275.59% | 44 | Sep 22, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $57 | $27.53 | +107.05% | 8 | Sep 22, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $90 | $27.88 | +222.81% | 40 | Sep 15, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $100 | $56.84 | +75.93% | 41 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $26.34 | +67.05% | 17 | Aug 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $18.23 | +207.19% | 24 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $13.06 | +206.28% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $20.30 | +166.01% | 25 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $108.82 | +56.22% | 4 | Aug 11, 2026 |
Viridian Therapeutics
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $19.03
Upside: +83.92%
Jade Biosciences
Sep 30, 2026
Reiterated: Buy
Price Target: $42
Current: $13.47
Upside: +211.80%
MoonLake Immunotherapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $33
Current: $9.55
Upside: +245.55%
Dianthus Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $125
Current: $72.09
Upside: +73.39%
Inventiva
Sep 28, 2026
Reiterated: Buy
Price Target: $14
Current: $2.94
Upside: +376.19%
Absci
Sep 24, 2026
Reiterated: Buy
Price Target: $16
Current: $8.25
Upside: +93.94%
Eledon Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $8
Current: $2.13
Upside: +275.59%
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $57
Current: $27.53
Upside: +107.05%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $27.88
Upside: +222.81%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $100
Current: $56.84
Upside: +75.93%
Aug 22, 2026
Reiterated: Buy
Price Target: $44
Current: $26.34
Upside: +67.05%
Aug 13, 2026
Reiterated: Buy
Price Target: $56
Current: $18.23
Upside: +207.19%
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $13.06
Upside: +206.28%
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $20.30
Upside: +166.01%
Aug 11, 2026
Reiterated: Buy
Price Target: $170
Current: $108.82
Upside: +56.22%